Member access

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

5
Delayed Quote. Delayed Nyse - 09/22 04:02:57 pm
55.31 USD   -0.29%
3d ago MEDNAX : Purchases MedData
09/10 MEDNAX : Acquires MedData
09/07 MEDNAX : TripleTree: Advisor to MedData in its Sale to Mednax
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
MEDNAX Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 5881 8172 1542 4142 6592 938
Operating income (EBITDA)381420492557607665
Operating profit (EBIT)355390452512559619
Pre-Tax Profit (EBT)-388448---
Net income218241281317345379
EPS ( $)2,242,432,783,153,433,77
Dividend per Share ( $)------
Yield------
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Finances - Leverage
MEDNAX Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt6,74116----
Finance--10,4125410317
Operating income (EBITDA)381420492557607665
Leverage
(Debt/EBITDA)
0,02x0,28x----
Capital Expenditure31,314,515,619,422,626,9
Book Value Per Share (BVPS)17,7 $20,3 $23,2 $25,3 $28,5 $33,2 $
Cash Flow per Share2,78 $3,28 $4,02 $3,91 $4,33 $4,98 $
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Balance Sheet Analysis
MEDNAX Inc : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 5 544 M$ -
Entreprise Value (EV) 5 420 M$ 5 134 M$
Valuation 2014e 2015e
PER (Price / EPS) 17,6x 16,1x
Capitalization / Revenue 2,30x 2,09x
EV / Revenue 2,25x 1,93x
EV / EBITDA 9,73x 8,46x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 21,2% 21,0%
operating Leverage (Delta EBIT / Delta Sales) 1,09x 0,91x
Net Margin (Net Profit / Revenue) 13,1% 13,0%
ROA (Net Profit / Asset) 9,70% 9,63%
ROE (Net Profit / Equities) 12,5% 4,04%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   0,80% 0,85%
Cash Flow / Sales (Taux d'autofinancement) 16,2% 16,3%
Capital Intensity (Assets / Sales) 1,35x 1,35x
Financial Leverage (Net Debt / EBITDA) -0,22x -0,68x
Price Earning Ratio
MEDNAX Inc : Price Earning Ratio
EPS & Dividend
MEDNAX Inc : EPS Dividend
Dynamic quotes  
ON
| OFF